The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prospective evaluation of low-dose ketoconazole plus hydrocortisone (HC) in chemotherapy-pretreated castration-resistant prostate cancer (CRPC) patients.
Ernest N. Lo
No relevant relationships to disclose
Laurel A. Beckett
No relevant relationships to disclose
Chong-xian Pan
No relevant relationships to disclose
Daniel Robles
No relevant relationships to disclose
Jennifer Marie Suga
No relevant relationships to disclose
Jacob Sands
No relevant relationships to disclose
Primo Lara
No relevant relationships to disclose